Management of Nausea in a Patient with Frequent Epistaxis and Hematemesis
In this patient with nausea, frequent nosebleeds, and old blood in gastric contents with dry heaves, you should first control the epistaxis with nasal compression and appropriate packing, then treat the nausea with dopamine receptor antagonists (metoclopramide 10-20 mg every 6 hours or prochlorperazine) while avoiding oral routes if vomiting persists—use rectal, subcutaneous, or intravenous administration instead. 1, 2
Critical First Step: Address the Epistaxis
The presence of old blood in gastric contents strongly suggests swallowed blood from posterior epistaxis is contributing to or causing the nausea. This must be addressed first:
- Immediate nasal compression: Apply firm sustained pressure to the soft part of the nose for at least 5 minutes 2, 3
- Identify bleeding site: Perform anterior rhinoscopy after clot removal, or nasal endoscopy if bleeding is difficult to control 2
- Nasal packing if needed: Use resorbable packing if the patient has bleeding disorders or is on anticoagulation/antiplatelet medications 3
- Topical vasoconstrictors: Apply oxymetazoline 0.05% spray to the bleeding site after anesthesia 2, 4
Key caveat: Posterior epistaxis can present as hematemesis and melena, mimicking upper GI bleeding 5, 6. The "specs of old blood" in gastric liquid likely represent swallowed blood rather than true gastric pathology.
Antiemetic Management Algorithm
Step 1: Initial Pharmacologic Therapy
Start with dopamine receptor antagonists as first-line agents for nonspecific nausea and vomiting 1, 7:
- Metoclopramide: 10-20 mg every 6 hours (also treats gastroparesis from swallowed blood) 1, 8
- Prochlorperazine: Alternative dopamine antagonist 1, 9
- Haloperidol: Another option, particularly useful for persistent symptoms 1, 7
Route selection is critical with dry heaves:
- Oral route is NOT feasible with ongoing vomiting 1, 9
- Use rectal suppositories, subcutaneous infusions, or intravenous administration 1, 10
- Consider around-the-clock dosing rather than PRN to prevent symptoms 9, 7
Step 2: If Nausea Persists After 4-8 Weeks
Titrate the dopamine antagonist to maximum benefit and tolerance, then add agents from different classes 1, 7:
- Add 5-HT3 antagonist (ondansetron 8 mg 2-3 times daily) 1, 11
- Add antihistamine (promethazine) or anticholinergic agent 1, 8
- Consider corticosteroids (dexamethasone 4-8 mg TID-QID) 1, 7
- Add benzodiazepine if anxiety contributes (lorazepam 0.5-2 mg every 4-6 hours) 11, 9
Step 3: Refractory Symptoms
For persistent nausea despite the above:
- Continuous IV or subcutaneous infusion of antiemetics 9, 7
- Olanzapine as an antipsychotic with antiemetic properties 1, 12
- Cannabinoids (dronabinol or nabilone) for refractory cases 1, 12
Additional Supportive Measures
Address gastritis from swallowed blood:
- Proton pump inhibitors or H2-receptor antagonists to manage gastric irritation from blood 1, 11
- This is particularly important as patients may have difficulty discriminating heartburn from nausea 11, 9
Ensure adequate hydration:
- Check and correct electrolyte abnormalities 11, 9
- Swallowed blood can cause volume depletion and electrolyte disturbances
Nasal care after epistaxis control:
- Keep nose moist with saline sprays to prevent rebleeding 2, 4
- Provide oxymetazoline 0.05% spray for home use if rebleeding occurs 4
Common Pitfalls to Avoid
Don't assume upper GI bleeding without ruling out epistaxis: Posterior nosebleeds commonly present as hematemesis 5, 6. The anchoring bias toward GI pathology can delay proper diagnosis.
Don't use oral antiemetics with active vomiting: This is ineffective and wastes time 1, 9, 10
Don't use single-agent therapy for persistent symptoms: Combination therapy targeting multiple receptor pathways is more effective 1, 7
Don't overlook medication causes: Review all current medications that may worsen nausea (opioids, digoxin, phenytoin) 1, 7
Don't pack the nose without proper follow-up instructions: Patients need clear guidance on packing removal timing, warning signs of complications (fever >101°F, vision changes, increasing pain), and activity restrictions 2
Evidence Quality Note
The strongest evidence supports metoclopramide for antiemesis unrelated to chemotherapy 1, though the overall evidence quality is moderate to weak. The epistaxis management recommendations are based on high-quality guidelines from the American Academy of Otolaryngology 2, 3, 2. The combination approach for refractory nausea represents expert consensus when single agents fail 1, 7.